Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease: results from the NHLBI Family Heart Study (Q77714432)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 December 1998

Language	Label	Description	Also known as
English	Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease: results from the NHLBI Family Heart Study	scientific article published on 01 December 1998

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862182%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease: results from the NHLBI Family Heart Study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862182%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

coronary artery disease

1 reference

based on heuristic

inferred from title

author name string

P N Hopkins

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862182%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

S C Hunt

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862182%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

P J Schreiner

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862182%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

J H Eckfeldt

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862182%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

I B Borecki

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862182%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

C R Ellison

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862182%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

R R Williams

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862182%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

K D Siegmund

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862182%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 December 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862182%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Atherosclerosis

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862182%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

141

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862182%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862182%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

333-345

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862182%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Familial lipoprotein disorders in patients with premature coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Lipoprotein[a] as a risk factor for preclinical atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Relation of coronary artery disease in women < 60 years of age to the combined elevation of serum lipoprotein (a) and total cholesterol to high-density cholesterol ratio

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Plasma Lp(a), apolipoprotein(a) isoforms and acute myocardial infarction in men and women: a case-control study in the Jerusalem population.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Haemostatic factors and prevalent coronary heart disease; the FINRISK Haemostasis Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Evidence that apolipoprotein(a) phenotype is a risk factor for coronary artery disease in men < 55 years of age

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Association of elevated lipoprotein(a) levels and coronary heart disease in NIDDM patients. Relationship with apolipoprotein(a) phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Serum lipoprotein(a) and coronary artery disease in uremic patients on chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Lipoprotein(a) in restenosis after percutaneous transluminal coronary angioplasty and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Plasma Lp(a) levels correlate with number, severity, and length-extension of coronary lesions in male patients undergoing coronary arteriography for clinically suspected coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Close relation between lipoprotein (a) levels and atherothrombotic disease in Japanese subjects > 75 years of age

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Dose-response relationships of serum lipid measurements with the extent of coronary stenosis. Strong, independent, and comprehensive. ECAT Angina Pectoris Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Serum Lp(a) lipoprotein levels in patients with coronary artery disease and the influence of long-term n-3 fatty acid supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Evaluation of lipoprotein (a) [Lp (a)] as a risk factor for coronary artery disease in the Turkish population

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Lack of increased coronary atherosclerotic risk due to elevated lipoprotein(a) in women > or = 55 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Lipoprotein(a) as a determinant of coronary heart disease in young women

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Determinants of severity of coronary artery disease in Australian men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Apolipoproteins and ischaemic heart disease: implications for screening

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS).

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a)

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Lipoprotein(a) interactions with lipid and nonlipid risk factors in early familial coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

NHLBI Family Heart Study: objectives and design

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

A comparison of positive family history definitions for defining risk of future disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

The relationship between serum levels of lipoprotein(a) and proteins associated with the acute phase response.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Lipoprotein(a) and acute-phase proteins in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Transient changes of serum lipoprotein(a) as an acute phase protein

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

[Rapid physiological coagulation method in determination of fibrinogen]

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Lipoprotein(a) and accelerated coronary artery disease in cardiac transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Race and gender differences in the association of Lp(a) with carotid artery wall thickness. The Atherosclerosis Risk in Communities (ARIC) Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

A comparison of Lp(a) levels in fresh and frozen plasma using ELISAs with either anti-apo(a) or anti-apoB reporting antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Lipoprotein(a) impairs generation of plasmin by fibrin-bound tissue-type plasminogen activator. In vitro studies in a plasma milieu

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Antifibrinolytic activity of apolipoprotein(a) in vivo: Human apolipoprotein(a) transgenic mice are resistant to tissue plasminogen activator-mediated thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Apolipoprotein(a) attenuates endogenous fibrinolysis in the rabbit jugular vein thrombosis model in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Interaction of lipoprotein Lp(a) and low density lipoprotein with glycosaminoglycans from human aorta

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Apolipoprotein(a) induces monocyte chemotactic activity in human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Lipoprotein (a) inhibits the generation of transforming growth factor beta: an endogenous inhibitor of smooth muscle cell migration

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Lipoprotein(a) induces cell growth in rat peritoneal macrophages through inhibition of transforming growth factor-beta activation

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Genomic instability in the type II TGF-beta1 receptor gene in atherosclerotic and restenotic vascular cells

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Oxidation of lipoprotein Lp(a). A comparison with low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Nutrient intake and progression of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Serum lipoprotein(a) concentrations are related to coronary disease progression without new myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein(a)

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Relation of plasma lipoprotein(a) to infarct artery patency in survivors of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Usefulness of serum lipoprotein (a) as a predictor of restenosis after percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

The relationship between serum lipoprotein(a) and restenosis after initial elective percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Prevention of restenosis after percutaneous transluminal coronary angioplasty by reducing lipoprotein (a) levels with low-density lipoprotein apheresis. Low-Density Lipoprotein Apheresis Angioplasty Restenosis Trial (L-ART) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Effectiveness of LDL-apheresis in preventing restenosis after percutaneous transluminal coronary angioplasty (PTCA): LDL-apheresis angioplasty restenosis trial (L-ART)

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Risk factors for restenosis after percutaneous transluminal coronary angioplasty: role of lipoprotein (a)

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Elevated serum lipoprotein(a) is a risk factor for clinical recurrence after coronary balloon angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Lipoprotein(a) in stored plasma samples and the ravages of time. Why epidemiological studies might fail

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

Differences in lipoprotein (a) and apolipoprotein (a) levels in men and women with advanced coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipoprotein (a) and coronary heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum Lp(a) as a discriminant marker of early atherosclerotic plaque at three extracoronary sites in hypercholesterolemic men. The PCVMETRA Group

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipoprotein(a), fibrin binding, and plasminogen activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900174-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0021-9150(98)00174-9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862182%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9862182%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77714432&oldid=2242955601"